albiglutide

A long-acting glucagon-like peptide-1 (GLP-1) receptor agonist, with antihyperglycemic activity. Albiglutide is composed of a GLP-1 (7-36) dimer… (More)

Topic mentions per year

Topic mentions per year

2008-2018
0102020082018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
BACKGROUND Albiglutide is a glucagon-like peptide-1 receptor agonist, a new class of drugs used to treat type 2 diabetes. We did… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 6
Is this relevant?
Highly Cited
2014
Highly Cited
2014
BACKGROUND As new members of a drug class are developed, head-to-head trials are an important strategy to guide personalised… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 3
Is this relevant?
2014
2014
OBJECTIVE GLP-1 receptor agonists may provide an alternative to prandial insulin for advancing basal insulin therapy. Harmony 6… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
Is this relevant?
2014
2014
OBJECTIVE To compare the efficacy and safety of weekly albiglutide with daily sitagliptin, daily glimepiride, and placebo… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
Is this relevant?
2014
2014
The aim of this study was to compare the efficacy and safety of once-weekly albiglutide with once-daily insulin glargine (A21Gly… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2014
2014
Albiglutide (Eperzan® [EU]; Tanzeum™ [US]), a glucagon-like peptide 1 receptor agonist, has been developed by GlaxoSmithKline for… (More)
Is this relevant?
2011
2011
BACKGROUND The cardioprotective effects of glucagon-like peptide-1 (GLP-1) and analogs have been previously reported. We tested… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2009
Highly Cited
2009
OBJECTIVE To evaluate the efficacy, safety, and tolerability of incremental doses of albiglutide, a long-acting glucagon-like… (More)
  • figure 1
  • figure 2
Is this relevant?
2009
2009
AIMS Albiglutide is a glucagon-like peptide-1 (GLP-1) mimetic generated by genetic fusion of a dipeptidyl peptidase-IV-resistant… (More)
Is this relevant?
2008
2008
CONTEXT Native glucagon-like peptide-1 increases insulin secretion, decreases glucagon secretion, and reduces appetite but is… (More)
Is this relevant?